DEPRESSION STUDY: INVESTIGATING LINKS BETWEEN SLEEP AND MOOD

  • STATUS
    Recruiting
Updated on 19 February 2024

Summary

GOAL: This research study aims to examine the role of slow-wave sleep activity in improving mood in individuals with Major Depressive Disorder (MDD).
TARGET POPULATION: We are looking for 40 currently depressed males and females and 20 healthy controls with no history of depression between the ages of 25-50. Participants must taper off of any psychiatric medication for duration of the study.
PARTICIPATION: Participation lasts for approximately one month. Participants will attend an initial 3-hour screening session (2-hour virtual, 1-hour in-person). Then, they will participate in one baseline night of sleep and one night where slow-wave sleep will be disrupted at the Hospital of the University of Pennsylvania Sleep Lab. Following each laboratory night, participants will complete a variety of tasks and questionnaires, including protocol for transcranial magnetic stimulation (TMS).

Description

Research procedures:
  1. 2-hour virtual screening session: discuss study details, sign consent form, complete questionnaires, interview about history of mental health symptoms
  2. 1-hour in-person visit (3535 Market Street): demonstration of TMS procedures, hearing test
  3. One week prior to overnight visits: wear a wrist-worn device to measure activity levels during the day and at night, fill out sleep diary every morning about previous night's sleep
  4. 2 overnight visits (Sleep Center at HUP): arrive at 8pm, wear sensors to measure your sleep; next morning, you will have a blood sample taken, be provided with breakfast, complete a few tasks, and complete the TMS protocol (ends around 11:30am at the latest); one of these two nights, tones will be played through a speaker to disrupt deep sleep without waking you up, the other night is baseline
Benefits of participation include contributing to the discovery of links between depressed mood and sleep, and contributing to a potential novel treatment for depression.  Risks include mild discomfort with blood draw and/or electrode placement, sleepiness/fatigue after disruption visit, and risks associated with TMS.

Compensation is $275 in total if you complete all study requirements.

Details
Condition healthy controls, Depression
Age 25years - 50years
Clinical Study IdentifierTX832986
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.